EUVIMEDEUVIMED entdecken
Klinische StudieVergleichsstudieRandomisierte kontrollierte Studie

Fumaric Acid Therapy in Psoriasis: A Double-Blind Comparison between Fumaric Acid Compound Therapy and Monotherapy with Dimethylfumaric Acid Ester

C Nieboer, D de Hoop, P N Langendijk, A C van Loenen, J Gubbels

Dermatologica · 2009

DOI: 10.1159/000247856 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Dermatologica, 2009. Verfasst von C Nieboer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Free University Hospital, Amsterdam, The Netherlands. Die Arbeit wurde bisher 70-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In a 4-month double-blind study the effects of dimethylfumaric acid esters (DMFAE-EC) and DMFAE plus salts of monoethylfumaric acid esters (fumaric acid combination, FAC-EC) in enteric-coated tablets were compared in 22 respectively 23 patients with psoriasis. In both groups about 50% showed a considerable improvement, i.e. the initial score was more than halved. The therapeutic effects showed no significant differences in both groups with respect to the total psoriasis score or the different parameters. In the FAC-EC group the effects were obtained more rapidly. Most frequently observed side effects in both groups were flushings, stomachache and diarrhea. Due to these complaints 3 respectively 8 patients discontinued therapy. Eosinophilia, leukopenia and lymphopenia were the most frequently observed differences in lab tests. It was concluded that FAC-EC had no significantly better effect than monotherapy with DMFAE-EC. Moreover, enteric coating of the tablets did not prevent stomach complaints. Until more information has been obtained about the pharmacokinetics, the toxicity and optimal composition of the drug, the fumaric acid therapy in psoriasis should be seen as experimental.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdolescentAdultAgedDimethyl FumarateDouble-Blind MethodDrug Therapy, CombinationEstersFemaleFumaratesHumansMaleMiddle AgedPsoriasisRandom Allocation

Substanzen

EstersFumaratesfumaric acidDimethyl Fumarate

Autor:innen und Institutionen

  • Department of Dermatology, Free University Hospital, Amsterdam, The Netherlands.

Zitieren

APA

Nieboer, C., de Hoop, D., Langendijk, P. N., van Loenen, A. C., & Gubbels, J. (2009). Fumaric Acid Therapy in Psoriasis: A Double-Blind Comparison between Fumaric Acid Compound Therapy and Monotherapy with Dimethylfumaric Acid Ester. Dermatologica. https://doi.org/10.1159/000247856

Vancouver

Nieboer C, de Hoop D, Langendijk PN, van Loenen AC, Gubbels J. Fumaric Acid Therapy in Psoriasis: A Double-Blind Comparison between Fumaric Acid Compound Therapy and Monotherapy with Dimethylfumaric Acid Ester. Dermatologica. 2009. doi:10.1159/000247856

BibTeX
@article{Nieboer2009,
  author = {Nieboer, C and de Hoop, D and Langendijk, P N and van Loenen, A C and Gubbels, J},
  title = {Fumaric Acid Therapy in Psoriasis: A Double-Blind Comparison between Fumaric Acid Compound Therapy and Monotherapy with Dimethylfumaric Acid Ester},
  journal = {Dermatologica},
  year = {2009},
  doi = {10.1159/000247856}
}
Kostenlos starten →